Evaluation of the effects of continuous use of test products on skin condition

Evaluation of the effects of continuous use of test products on skin condition - Evaluation of the effects of continuous use of test products on skin condition

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000062021

Enrollment

Registered

2026-06-23

Start date

2026-06-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Continuous use of the test products

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Men or women 2. Adults (aged 22 to 59) 3. Healthy individuals

Exclusion criteria

Exclusion criteria: 1. Individuals with severe skin conditions, such as dermatitis 2. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 3. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 4. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, metabolic bone disorders, including osteoporosis and fractures, or any other chronic diseases 5. Individuals who are unable to avoid intentional sun exposure, such as sunbathing, during the study period 6. Individuals with known allergies to medications or test-related substances 7. Individuals who have a present condition or have a medical history of drug or alcohol dependence 8. Individuals who are pregnant, lactating, or planning to become pregnant during this study 9. Individuals who currently or within the past month have a habit of continuous oral intake or topical application of drugs claiming skin improvement benefits, or who are otherwise judged by the principal investigator to be inappropriate for this study 10. Individuals who are using cosmetics with strong moisturizing or anti-wrinkle effects 11. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

Measure	Time frame
Changes in skin condition parameters following intervention (measured values and images)	—

Secondary

Measure	Time frame
Changes in skin condition parameters following intervention (absolute changes and percentage changes)	—

Countries

Japan

Contacts

Public ContactSaki Shirako

Pharma Foods International Co., Ltd. R&D Department

saki-shirako@pharmafoods.co.jp075-748-9829

Outcome results